LiuLWangDWongKSWangY. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke2011; 42: 3651–3654.
2.
ZhanCHeX. The current situation of stroke prevention and treatment in China by academician Longde Wang. Chin Med Pharm Sci2011; 1: 3.
3.
ZhouMWangHZhuJet al.Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet2016; 387: 251–272.
4.
TianDYangQDongQLiNYanBFanD. Trends in stroke subtypes and vascular risk factors in a stroke center in China over 10 years. Sci Rep2018; 8: 5037.
5.
WangJZhangLWangFLiuLWangH. Prevalence, awareness, treatment, and control of hypertension in China: results from a National Survey. Am J Hypert2014; 27: 1355–1361.
6.
WangWWangDLiuHet al.Trend of declining stroke mortality in China: reasons and analysis. Stroke Vasc Neurol2017; 2: 132–139.
7.
LiZWangCZhaoXet al.Substantial progress yet significant opportunity for improvement in stroke care in China. Stroke2016; 47: 2843–2849.
8.
WangWJiangBSunHet al.Prevalence, Incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation2017; 135: 759–771.
9.
WenWZhangCHuangQet al.Effect of quality surveillance and continuous improvement on the diagnosis and treatment of acute ischemic stroke. J Chin Cerebrovas Dis2017; 14: 169–174.
10.
LingYChengXFangKHuZDongQ. Optimization of the protocol for emergent management of acute ischemic stroke to increase the efficacy of rt-PA thrombolysis. Prac J Clin Med2013; 10: 17–19.
11.
DongQDongYLiuLet al.The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke. Stroke Vasc Neurol2017; 2: 147–159.
12.
WangYLiZZhaoXet al.Stroke care quality in China: substantial improvement, and a huge challenge and opportunity. Int J Stroke2017; 12: 229–235.
13.
FeiginVLNorrvingBMensahGA. Global burden of stroke. Circ Res2017; 120: 439–448.
